Aptose Biosciences Inc (APS) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.381x

Based on the latest financial reports, Aptose Biosciences Inc (APS) has a cash flow conversion efficiency ratio of 0.381x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-7.41 Million ≈ $-5.36 Million USD) by net assets (CA$-19.45 Million ≈ $-14.07 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Aptose Biosciences Inc - Cash Flow Conversion Efficiency Trend (1996–2024)

This chart illustrates how Aptose Biosciences Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Aptose Biosciences Inc total liabilities for a breakdown of total debt and financial obligations.

Aptose Biosciences Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Aptose Biosciences Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
zSpace, Inc. Common stock NASDAQ:ZSPC	0.125x
Nichols LSE:NICL	0.169x
Tartana Minerals Ltd AU:TAT	-0.217x
Yunji Inc NASDAQ:YJ	N/A
Simble Solutions Ltd AU:SIS	1.447x
Foresight Solar Fund Ltd LSE:FSFL	0.015x
Terregra Asia Energy PT JK:TGRA	-0.007x
Gratomic Inc V:GRAT	-0.003x

Annual Cash Flow Conversion Efficiency for Aptose Biosciences Inc (1996–2024)

The table below shows the annual cash flow conversion efficiency of Aptose Biosciences Inc from 1996 to 2024. For the full company profile with market capitalisation and key ratios, see Aptose Biosciences Inc market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CA$-4.54 Million ≈ $-3.29 Million	CA$-35.98 Million ≈ $-26.03 Million	7.919x	-48.48%
2023-12-31	CA$-2.90 Million ≈ $-2.10 Million	CA$-44.59 Million ≈ $-32.26 Million	15.371x	+1894.75%
2022-12-31	CA$37.74 Million ≈ $27.30 Million	CA$-32.32 Million ≈ $-23.38 Million	-0.856x	-46.82%
2021-12-31	CA$74.24 Million ≈ $53.70 Million	CA$-43.30 Million ≈ $-31.33 Million	-0.583x	-104.68%
2020-12-31	CA$118.92 Million ≈ $86.02 Million	CA$-33.89 Million ≈ $-24.52 Million	-0.285x	-24.17%
2019-12-31	CA$93.93 Million ≈ $67.94 Million	CA$-21.56 Million ≈ $-15.59 Million	-0.230x	+86.07%
2018-12-31	CA$14.08 Million ≈ $10.19 Million	CA$-23.21 Million ≈ $-16.79 Million	-1.648x	-64.47%
2017-12-31	CA$10.20 Million ≈ $7.38 Million	CA$-10.22 Million ≈ $-7.40 Million	-1.002x	+39.69%
2016-12-31	CA$7.33 Million ≈ $5.30 Million	CA$-12.17 Million ≈ $-8.81 Million	-1.661x	-129.30%
2015-12-31	CA$13.65 Million ≈ $9.87 Million	CA$-9.89 Million ≈ $-7.15 Million	-0.725x	-84.19%
2014-12-31	CA$25.28 Million ≈ $18.28 Million	CA$-9.94 Million ≈ $-7.19 Million	-0.393x	-106.04%
2013-12-31	CA$-757.75K ≈ $-548.15K	CA$-4.94 Million ≈ $-3.57 Million	6.516x	+296.38%
2012-12-31	CA$-1.95 Million ≈ $-1.41 Million	CA$-3.21 Million ≈ $-2.32 Million	1.644x	+106.67%
2011-12-31	CA$244.66K ≈ $176.99K	CA$-6.03 Million ≈ $-4.36 Million	-24.661x	-459.21%
2010-12-31	CA$-513.68K ≈ $-371.59K	CA$-3.53 Million ≈ $-2.55 Million	6.865x	+694.85%
2009-12-31	CA$-7.66 Million ≈ $-5.54 Million	CA$-6.62 Million ≈ $-4.79 Million	0.864x	-67.36%
2008-12-31	CA$-3.87 Million ≈ $-2.80 Million	CA$-10.25 Million ≈ $-7.42 Million	2.646x	+131.98%
2007-12-31	CA$711.16K ≈ $514.45K	CA$-5.88 Million ≈ $-4.26 Million	-8.274x	-261.85%
2006-12-31	CA$-2.32 Million ≈ $-1.68 Million	CA$-11.87 Million ≈ $-8.58 Million	5.112x	+462.25%
2005-12-31	CA$10.57 Million ≈ $7.65 Million	CA$-14.92 Million ≈ $-10.79 Million	-1.411x	0.00%
2004-12-31	CA$10.57 Million ≈ $7.65 Million	CA$-14.92 Million ≈ $-10.79 Million	-1.411x	-43.83%
2003-12-31	CA$20.99 Million ≈ $15.19 Million	CA$-20.60 Million ≈ $-14.90 Million	-0.981x	-263.72%
2002-12-31	CA$28.89 Million ≈ $20.90 Million	CA$-7.79 Million ≈ $-5.64 Million	-0.270x	0.00%
2001-12-31	CA$28.89 Million ≈ $20.90 Million	CA$-7.79 Million ≈ $-5.64 Million	-0.270x	-56.21%
2000-12-31	CA$36.38 Million ≈ $26.32 Million	CA$-6.28 Million ≈ $-4.55 Million	-0.173x	-121.46%
1999-12-31	CA$45.89 Million ≈ $33.19 Million	CA$-3.58 Million ≈ $-2.59 Million	-0.078x	+95.88%
1998-12-31	CA$1.29 Million ≈ $932.14K	CA$-2.44 Million ≈ $-1.77 Million	-1.895x	-106.70%
1997-12-31	CA$3.30 Million ≈ $2.38 Million	CA$-3.02 Million ≈ $-2.19 Million	-0.917x	-141.90%
1996-12-31	CA$6.89 Million ≈ $4.99 Million	CA$-2.61 Million ≈ $-1.89 Million	-0.379x	--

About Aptose Biosciences Inc

TO:APS Canada Biotechnology

Market Cap

$4.36 Million

CA$6.02 Million CAD

Market Cap Rank

#28621 Global

#1322 in Canada

Share Price

CA$2.36

Change (1 day)

+0.85%

52-Week Range

CA$1.09 - CA$2.80

All Time High

CA$181.05